Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to improve glycemic control in adults ...

Biocon Ltd. shares may rise following the USFDA's approval of its key diabetes treatment drug, Kristy, potentially enhancing insulin accessibility and affordability.